SCHEMBL275136

SCHEMBL275136

CC(C)(C)[Si](C)(C)OCCOc1ccc(Oc2ccc(Cl)cc2C=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
S1PR4 O95977 2/20 0.36
ORAI1 Q96D31 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARA Q07869 1/20 0.35
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
KCNH2 Q12809 1/20 0.34
EPAS1 Q99814 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NPC1 O15118 1/20 0.34
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2151914 0.89 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EPKMS1PR4
SCHEMBL275040 0.86 ALDH1A1 (0.34) ALDH1A1MAPTKMT2APPARALMNA
SCHEMBL274698 0.86 PPARA (0.41) ALDH1A1MAPTKMT2APPARALMNA
SCHEMBL279201 0.80 HPGD (0.37) ALDH1A1MAPTKDM4EKMT2APPARA
SCHEMBL275854 0.78 MAPT (0.42) ALDH1A1MAPTKDM4EPKMKMT2A
SCHEMBL1957317 0.77 XDH (0.38) ALDH1A1ORAI1KMT2AKCNH2CA12
SCHEMBL17558158 0.77 TUBB1 (0.41) ALDH1A1MAPTKDM4ELMNAHPGD
SCHEMBL17558097 0.76 TUBB1 (0.43) ALDH1A1MAPTKDM4EPKMLMNA
SCHEMBL278950 0.75 ERN1 (0.42) ALDH1A1KDM4EPKMS1PR4KMT2A
SCHEMBL664995 0.75 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
EP-2229396-B1 SPIROINDOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-08-10 EP disclosed
EP-2229396-A1 SPIROINDOLINONE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-09-22 EP disclosed
WO-2009077357-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT ALDH1A1 138/4885MAPT 4062/4885KDM4E 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.